Patient education programs should be used in primary care centers and hospital settings to correct common misconceptions about hypertension.
Health education campaigns should address culturally rooted beliefs (such as blood viscosity and stress) using locally tailored language and examples.
Support adherence by strategies such as medication counseling, pill boxes, reminder systems, and family involvement.
Physicians and nurses should be trained to identify and address patient misconceptions during consultations making health education part of routine care.
Public health campaigns through mass media, mosques, and community gatherings could help disseminate accurate information about hypertension.
Conduct further studies to confirm these associations and to evaluate the impact of educational interventions on long-term outcomes.
Study Limitations
The sample size was drawn from a single medical center, which may limit the generalizability of the findings to the wider hypertensive population in Iraq.
The cross-sectional design and lack of follow up cannot establish causal relationships between beliefs, adherence, outcome and improvements after interventions.
Adherence was assessed using self-reported tools (MMAS-8) which contains subjective measures.
Some unmeasured factors, such as income level, or access to healthcare services, could not be fully evaluated.
References
Gupta R, Xavier D. Hypertension: The most important non communicable disease risk factor in India. Indian heart journal. 2018 Jul 1;70(4):565-72.
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nature Reviews Nephrology. 2020 Apr;16(4):223-37.
Nugroho P, Andrew H, Kohar K, Noor CA, Sutranto AL. Comparison between the world health organization (WHO) and international society of hypertension (ISH) guidelines for hypertension. Annals of medicine. 2022 Dec 31;54(1):837-45.
Mohammadian Khonsari N, Shahrestanaki E, Ejtahed HS, Djalalinia S, Sheidaei A, Hakak-Zargar B, Heshmati J, Mahdavi-Gorabi A, Qorbani M. Long-term trends in hypertension prevalence, awareness, treatment, and control rate in the Middle East and North Africa: a systematic review and meta-analysis of 178 population-based studies. Current hypertension reports. 2021 Sep;23(9):41.
Saxena T, Ali AO, Saxena M. Pathophysiology of essential hypertension: an update. Expert review of cardiovascular therapy. 2018 Dec 2;16(12):879-87.
Flint AC, Conell C, Ren X, Banki NM, Chan SL, Rao VA, Melles RB, Bhatt DL. Effect of systolic and diastolic blood pressure on cardiovascular outcomes. New England Journal of Medicine. 2019 Jul 18;381(3):243-51.
Chobufo MD, Gayam V, Soluny J, Rahman EU, Enoru S, Foryoung JB, Agbor VN, Dufresne A, Nfor T. Prevalence and control rates of hypertension in the USA: 2017–2018. International Journal of Cardiology Hypertension. 2020 Sep 1;6:100044.
Hong D, Shan W. Improvement in hypertension management with pharmacological and non-pharmacological approaches: current perspectives. Current Pharmaceutical Design. 2021 Mar 1;27(4):548-55.
Ritchey MD, Gillespie C, Wozniak G, Shay CM, Thompson‐Paul AM, Loustalot F, Hong Y. Potential need for expanded pharmacologic treatment and lifestyle modification services under the 2017 ACC/AHA Hypertension Guideline. The Journal of Clinical Hypertension. 2018 Oct;20(10):1377-91.
Poulter NR, Borghi C, Parati G, Pathak A, Toli D, Williams B, Schmieder RE. Medication adherence in hypertension. Journal of hypertension. 2020 Apr 1;38(4):579-87.
Burnier M, Egan BM. Adherence in hypertension: a review of prevalence, risk factors, impact, and management. Circulation research. 2019 Mar 29;124(7):1124-40.
Hamrahian SM, Maarouf OH, Fülöp T. A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider. Patient preference and adherence. 2022 Jan 1:2749-57.
Satoh M, Muroya T, Murakami T, Obara T, Asayama K, Ohkubo T, Imai Y, Metoki H. The impact of clinical inertia on uncontrolled blood pressure in treated hypertension: real-world, longitudinal data from Japan. Hypertension Research. 2024 Mar;47(3):598-607.
Blacher J, Levy BI, Mourad JJ, Safar ME, Bakris G. From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century. The Lancet. 2016 Jul 30;388(10043):530-2.
Khaleefah MA, Al-Badri HJ, Mousa NA. Hypertension control among adult Iraqis. J Fac Med Baghdad. Vol. 64 No. 3 (2022).
Song JJ, Ma Z, Wang J, Chen LX, Zhong JC. Gender differences in hypertension. Journal of cardiovascular translational research. 2020 Feb;13(1):47-54.
Soliman SS, Guseman EH, Haile ZT, Ice G. Prevalence and determinants of hypertension unawareness among Egyptian adults: the 2015 EHIS. Journal of human hypertension. 2021 Oct;35(10):927-34.
Lee KS, Lee J. The complex relationship between treatment burden of multimorbidity and self-care in multimorbid patients with hypertension. BMC Primary Care. 2025 Jul 9;26(1):219.
Diaconu CC, Cozma MA, Dobrică EC, Gheorghe G, Jichitu A, Ionescu VA, Nicolae AC, Drăgoi CM, Găman MA. Polypharmacy in the management of arterial hypertension—friend or foe?. Medicina. 2021 Nov 23;57(12):1288.
Alhaddad A, Sofar S, Alhofaian A. Self-Management practice Gaps among Patients with Hypertension in KSA: Narrative Review. Evidence-Based Nursing Research. 2021 Jan 1;3(1):30-9.
Aminde LN, Agbor VN, Fongwen NT, Ngwasiri CA, Nkoke C, Nji MA, Dzudie A, Schutte AE. High Burden and Trend in Nonadherence to Blood Pressure‐Lowering Medications: Meta‐Analysis of Data From Over 34 000 Adults With Hypertension in Sub‐Saharan Africa. Journal of the American Heart Association. 2025 May 6;14(9):e037555.
Goodhart AK. Hypertension from the patient’s perspective. British Journal of General Practice. 2016 Nov 1;66(652):570-.
Messerli FH, Rimoldi SF. Misconceptions and facts about treating hypertension. Current Opinion in Cardiology. 2015 Jul 1;30(4):359-60.
Otemah J, Ohene LA, Kyei J, Owusu-Darkwa I. Beliefs and misconceptions about hypertension disease: A qualitative study among patients in a peri-urban community in Ghana. Chronic Illness. 2025 Mar;21(1):56-67.
Sabaté E, editor. Adherence to long-term therapies: evidence for action. World health organization; 2003.
Spencer S. Lessons from the PURE study. Global Cardiology Science and Practice. 2015 Feb 1;2014(4):52.
Fihaya FY, Sofiatin Y, Ong PA, Sukandar H, Roesli RM. Prevalence of hypertension and its complications in Jatinangor 2014. Journal of Hypertension. 2015 Jun 1;33:e35.
Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP. Barriers and facilitators of medication adherence in hypertensive African Americans. Ethnicity & disease. 2004 Jan 1;14(1):3-12.